Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PEGINTERFERON LAMBDA-1A for Hepatitis c: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where PEGINTERFERON LAMBDA-1A was used for Hepatitis c.

Most Reported Side Effects for PEGINTERFERON LAMBDA-1A

Side Effect Reports % Deaths Hosp.
Jaundice 18 25.7% 2 6
Rash 18 25.7% 5 11
Alanine aminotransferase increased 8 11.4% 0 2
Aspartate aminotransferase increased 8 11.4% 0 2
Hyperbilirubinaemia 7 10.0% 1 2
Pyrexia 7 10.0% 6 4
Ascites 6 8.6% 6 3
Haemoglobin decreased 6 8.6% 1 2
Hepatic failure 6 8.6% 6 3
Sleep disorder 6 8.6% 0 6
Affective disorder 5 7.1% 0 5
Cholestasis 5 7.1% 5 2
Dizziness 5 7.1% 0 5
Encephalopathy 5 7.1% 5 2
Epilepsy 5 7.1% 0 5

Other Indications for PEGINTERFERON LAMBDA-1A

Chronic hepatitis c (60) Antiviral treatment (5)

Other Drugs Used for Hepatitis c

RIBAVIRIN (20,657) PEGINTERFERON ALFA-2A (10,970) LEDIPASVIR\SOFOSBUVIR (8,924) DASABUVIR\OMBITASVIR\PARITAPREVIR\RITONAVIR (8,264) SOFOSBUVIR (7,691) SOFOSBUVIR\VELPATASVIR (4,956) GLECAPREVIR\PIBRENTASVIR (4,016) OMBITASVIR\PARITAPREVIR\RITONAVIR (2,906) TELAPREVIR (2,604) DASABUVIR (2,603)

Related Pages

PEGINTERFERON LAMBDA-1A Full Profile All Hepatitis c Drugs PEGINTERFERON LAMBDA-1A Demographics PEGINTERFERON LAMBDA-1A Timeline